Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1

• Mougina K. Eltahir,

  Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  https://orcid.org/0000-0002-2407-7710

  ⨯
• Masayuki Nakamori,

  Roles Conceptualization, Methodology, Resources, Writing – review & editing

  Affiliation Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Satoshi Hattori,

  Roles Methodology, Writing – review & editing

  Affiliation Department of Biomedical Statistics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Takashi Kimura,

  Roles Methodology, Writing – review & editing

  Affiliation Department of Neurology, Hyogo Medical University, Nishinomiya, Japan

  ⨯
• Hideki Mochizuki,

  Roles Funding acquisition, Methodology, Project administration, Resources, Writing – review & editing

  Affiliation Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Seiichi Nagano

  Roles Funding acquisition, Methodology, Resources, Supervision, Writing – review & editing

  * E-mail: nagano@neurol.med.osaka-u.ac.jp

  Current address: Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  Affiliation Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯